CoChat

Cell-type Specific Protoporphyrin IX Metabolism in Human Bladder Cancer in vitro¶

Krieg, René C., Fickweiler, Sonja, Wolfbeis, Otto S., Knuechel, Ruth · 2007 · Photochemistry and Photobiology
Cited by 113

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

5-Aminolevulinic acid (ALA)-supported fluorescence endoscopy of the urinary bladder results in a detection rate of bladder cancer superior to that of white light endoscopy. The different accumulation of the metabolite protoporphyrin IX (PPIX) in tumor cells after ALA instillation is poorly understood; however, it is crucial to optimize diagnosis and potential phototherapy. For systematic analysis of cell-type specific PPIX accumulation and metabolism two human bladder carcinoma cell lines (RT4 and J82), a normal urothelial cell line (UROtsa), and a fibroblast cell line (N1) were chosen, and grown in two different growth states to model important tissue components of the urinary bladder, i.e. tumor, normal epithelium and stroma. To quantitate PPIX content, fluorescence intensities measured by flow cytometry were matched with cellular PPIX extraction values, and related to relative ferrochelatase activity, cellular iron content, number of transferrin receptors per cell and porphobilinogen deaminase (PBGD) activity. For in vitro experiments, the initial correlation of relative flow cytometric and spectrometric measurements of PPIX provides a calibration curve for consequent flow cytometric PPIX quantification. Lower fluorescence of normal cells could be explained by significant differences of ferrochelatase activity and iron content in comparison to tumor cells. However, the content of iron was not related to transferrin receptor content. PBGD activity seemed to play a minor role for the differential accumulation of PPIX in urothelial cells. In conclusion, the in vitro culture of urothelial cells and fibroblasts indicates that the most important metabolic step for PPIX accumulation in the urinary bladder is the transition from PPIX to heme. Further investigation of PPIX metabolism does support the validation of photodynamic diagnosis, and might also lead the way to a highly specific tumor related molecule.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1562/0031-8655(2000)0720226ctspim2.0.co2

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 36

  1. Kriegmair, 1992, Intravesikale Instillation von Delta-Aminolävulinsäure (ALA)-eine neue Methode zur photodynamischen Diagnostik und Therapie, Laser Med, 8, 83
  2. Jichlinski, 1997, Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results, Lasers Surg. Med, 20, 402, 10.1002/(SICI)1096-9101(1997)20:4<402::AID-LSM5>3.0.CO;2-U · DOI · Paper page
  3. Filbeck, 1999, Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid, J. Endourol, 13, 117, 10.1089/end.1999.13.117 · DOI
  4. Kriegmair, 1996, Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer, Br. J. Urol, 77, 667, 10.1046/j.1464-410X.1996.09717.x · DOI · Paper page
  5. Waidelich, 1998, Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors, J. Urol, 159, 401, 10.1016/S0022-5347(01)63932-6 · DOI
  6. Malik, 1987, Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins, Br. J. Cancer, 56, 589, 10.1038/bjc.1987.246 · DOI · Paper page
  7. Kennedy, 1992, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol, 14, 275, 10.1016/1011-1344(92)85108-7 · DOI
  8. El-Sharabasy, 1992, Porphyrin metabolism in some malignant diseases, Br. J. Cancer, 65, 409, 10.1038/bjc.1992.83 · DOI · Paper page
  9. Ortel, 1993, Lethal photosensitization by endogenous porphyrins of PAM cells-modification by desferrioxamine, J. Photochem. Photobiol. B: Biol, 17, 273, 10.1016/1011-1344(93)80025-5 · DOI
  10. Keberle, 1964, The biochemistry of desferrioxamine and its relation to iron metabolism, Ann. N Y Acad. Soc, 19, 758, 10.1111/j.1749-6632.1965.tb54077.x · DOI · Paper page
  11. Jakobs, 1977, Low molecular weight intracellular iron transport compounds, Blood, 50, 433, 10.1182/blood.V50.3.433.433 · DOI · Paper page
  12. Hilf, 1999, Effect of delta-aminolevulinic acid on protoporhyrin IX accumulation in tumor cells transfected with plasmids containing porhobilinogen deaminase DNA, Photochem. Photobiol, 70, 334
  13. Petzoldt, 1995, Immortalisation of human urothelial cells, Urol. Res, 23, 377, 10.1007/BF00698738 · DOI
  14. Schuster, 1994, A heterologous in vitro coculture system to study interaction between human bladder cancer cells and fibroblasts, J. Urol, 151, 1707, 10.1016/S0022-5347(17)35349-1 · DOI
  15. Siedel, 1984, AACC-meeting abstract, Clin. Chem, 30, 975
  16. Carter, 1971, Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine), Anal. Biochem, 40, 450, 10.1016/0003-2697(71)90405-2 · DOI · Paper page
  17. Lauber, 1980, Bestimmung von Eisen im Serum: Methodenvergleich Teepol/Dithionit/Bathophenanthrolin gegen Guanidin/Ascorbinsäure/Ferrozin, J. Clin. Chem. Clin. Biochem, 18, 147
  18. Trowbridge, 1995, Overview of CD71, Leucocyte Typing, V, 1139
  19. Brockhoff, 1994, Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines, Cytometry, 17, 75, 10.1002/cyto.990170110 · DOI
  20. Groß, 1997, Haem precursors and porphobilinogen deaminase in erythrocytes and lymphocytes of patients with acute intermittent porphyria, Cell. Mol. Biol, 43, 29
  21. Steinbach, 1995, Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid, Photochem. Photobiol, 62, 887, 10.1111/j.1751-1097.1995.tb09152.x · DOI · Paper page
  22. Schoenfeld, 1994, Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterisation of photodynamic inactivation, Int. J. Cancer, 56, 106, 10.1002/ijc.2910560119 · DOI · Paper page
  23. He, 1993, Effect of UVA and blue light on porphyrin biosynthesis on epidermal cells, Photochem. Photobiol, 57, 825, 10.1111/j.1751-1097.1993.tb09218.x · DOI · Paper page
  24. Washbrook, 1997, Stimulation of tetrapyrrole synthesis in mammalian epithelial cells in culture by exposure to aminolevulinic acid, Br. J. Cancer, 75, 381, 10.1038/bjc.1997.62 · DOI
  25. Wyld, 1997, Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX, Br. J. Cancer, 76, 705, 10.1038/bjc.1997.450 · DOI · Paper page
  26. Moan, 1998, Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle, Int. J. Cancer, 75, 134, 10.1002/(SICI)1097-0215(19980105)75:1<134::AID-IJC20>3.0.CO;2-F · doi:10.1002/(sici)1097-0215(19980105)75:1<134::aid-ijc20>3.0.co;2-f
  27. Camadro, 1981, A simple ferrochelatase assay, Biochimie, 63, 463, 10.1016/S0300-9084(81)80022-3 · doi:10.1016/s0300-9084(81)80022-3
  28. Li, 1999, Effect of mammalian cell differentiation on response to exogenous 5-aminolevulinic acid, Photochem. Photobiol, 69, 231, 10.1111/j.1751-1097.1999.tb03279.x · DOI
  29. Schick, 1995, Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy, Acta Derm. Venereol. (Stockh.), 75, 276, 10.2340/0001555575276279 · DOI
  30. Knuechel, 1998, Human Cancer Cell Lines, 213
  31. Harper, 1987, Medizinische Biochemie, 10.1007/978-3-662-22150-1 · doi:10.1007/978-3-662-22150-1
  32. Simpson, 1977, Effects on the activity of ferrochelatase, Biochem. Biophys. Acta, 482, 461
  33. Rebeiz, 1992, Photodestruction of tumour cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenanthroline, Photochem. Photobiol, 55, 431, 10.1111/j.1751-1097.1992.tb04258.x · DOI · Paper page
  34. Bourgeade, 1992, Post-transcriptional regulation of transferrin receptor mRNA by IFN gamma, Nucleic-Acids Res, 20, 2997, 10.1093/nar/20.12.2997 · DOI · Paper page
  35. Elliott, 1993, Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study, Ann. N Y Acad. Sci, 698, 159, 10.1111/j.1749-6632.1993.tb17204.x · DOI · Paper page
  36. Pourzand, 1999, The iron regulatory protein can determine the effectiveness of 5-aminolevulinic acid in inducing protoporphyrin IX in human primary skin fibroblasts, J. Investig. Dermatol, 112, 419, 10.1046/j.1523-1747.1999.00556.x · DOI

Cited by

See all 113

Metadata

Authors
Krieg, R. C., Fickweiler, S., Wolfbeis, O. S., & Knuechel, R.
Venue
Photochemistry and Photobiology
Published
2007-05-01
Volume
72
Issue
2
Pages
226-233
ISSN
0031-8655 (ISSN-L)
OpenAlex
W1918512844
Cited by
113
References
12
FWCI
4.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cell-type Specific Protoporphyrin IX Metabolism in Human Bladder Cancer in vitro¶. https://app.cochat.ai/papers/10.1562/0031-8655(2000)0720226ctspim2.0.co2
The paper
Krieg, R. C., Fickweiler, S., Wolfbeis, O. S., & Knuechel, R. (2007). Cell-type Specific Protoporphyrin IX Metabolism in Human Bladder Cancer in vitro¶. Photochemistry and Photobiology. https://doi.org/10.1562/0031-8655(2000)0720226ctspim2.0.co2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.